Recipharm, a global CDMO, has announced that it has extended its high potency offering at its Leganés site in Spain to GMP pilot scale, giving customers a single high containment route from development to commercial supply.
Sterling Pharma Solutions has announced completion of an additional, large-scale GMP manufacturing suite at its dedicated bioconjugation facility in the UK, which will double capacity, as well as increasing the scale of manufacturing to 500L.
Hovione has announced it will commission the "world’s first" ConsiGma CDC Flex – a next generation continuous tableting line – at its East Windsor, New Jersey campus in late 2027.
Rooftop solar panels are becoming an increasingly important part of the energy strategies for organisations in the pharmaceutical sector, reports specialist electrical and solar panel contractors, Fusion 360.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), continues to expand its commercial fill-and-finish network to further strengthen its global manufacturing operations and support the evolving needs of pharma and biotech customers.
IMA Life North America, part of IMA Group, held a Grand Opening Ceremony in Tonawanda for the new 120,000-square-foot facility built to increase its production of freeze-drying equipment for the pharmaceutical industry.
Onyx Scientific has announced an investment of more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities, and increase capacity for commercial active pharmaceutical ingredient (API) production at the company’s Sunderland UK facility.
Syntegon, a strategic lifecycle partner to the pharmaceutical, biotech, and food industries, has opened its new OSD Customer Center in Fellbach following the move from Waiblingen.
Hovione has completed expansion of the company’s tablet development and manufacturing centre at its main global campus in Loures adding 25% more commercial-scale batch tableting capacity for the integrated supply of oral solid dosage products.
SGS has expanded its Saint-Benoît laboratory, a strategic site dedicated to pharmaceutical bioanalysis and drug development for the pharmaceutical and biotechnology industries.
Enzene has announced the launch of NeX, a transformative end-to-end partnership model that enables governments, institutions, and biopharma organisations to establish biomanufacturing capabilities wherever they need them.
